Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: Analysis of prostate volume and therapeutic outcome

BJU International

Volumn 86, Issue 4, 2000, Pages 439-442

  Sokeland ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Benign prostatic hyperplasia; Efficacy; Finasteride; PRO 160 120; Prostate volume; Sabal; Safety; Saw palmetto; Urtica extract

Indexed keywords

FINASTERIDE; PROSTAGUTT FORTE; SABAL EXTRACT; URTICA EXTRACT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MICTURITION; MULTICENTER STUDY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANGIOSPERMS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; ENZYME INHIBITORS; FINASTERIDE; HUMANS; MALE; MIDDLE AGED; ORGAN SIZE; PHYTOTHERAPY; PLANT EXTRACTS; PROSTATIC HYPERPLASIA; SERENOA; TREATMENT OUTCOME; URINATION DISORDERS; URODYNAMICS;

EID: 0033822484     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2000.00776.x     Document Type: Article

References (39)

1. Koch E, Biber A. Pharmakologische Wirkungen von Sabalund Urtikaextrakten als Grundlage für eine rationale medikamentöse Therapie der benignen Prostatahyperplasie. Urologe (B) 1994: 34: 90-5
2. Metzker H, Kieser M, Kölscher U. Wirksamkeit eines SabalUrtica-Kombinationspräparates bei der Behandlung der benignen Prostatahyperplasie (BPH). Urologe (B) 1996: 36: 292-300
3. Schneider H-J. Honold E. Masuhr T. Behandlung der benignen Prostatahyperplasie. Fortschr Med 1995: 113: 25-8
4. Geller ]. Five-year-follow-up of patients with benign prostatic hyperplasia treated with finasteride. Eur Urol 1995; 27: 267-73
5. Gormley GJ. Stoner E, Bruskewitz RC et al. The effect of finasteride in men with benign prostatic hyperplasia. New Eng} ] Med 1992: 327: 1185-91
6. Moore E, Bracken B, Bremner W et al. Proscar K : Five-yearexperience. Eur Urol 1995: 28: 304-9
7. The Finasteride Study Group. Finasteride (MK-906) in the treatment of benign prostatic hyperplasia. Prostate 1993; 22: 291-9
8. Tammela TLJ. Matti JK. Long-term effects of finasteride on invasive urodynamics and symptoms in the treatment of patients with bladder outflow obstruction due to benign prostatic hyperplasia. / Urol 1995: 154: 1466-9
9. Sökeland J. Albrecht J. Kombination aus Sabal- und Urticaextrakt vs. Finasterid bei BPH (Stad. I Bis II Nach Alken). Urologe (A) 1997; 36: 327-33
10. Boyle P. Gould AL. Roehrborn CG. Prostate volume predicts outcome of treatment of BPH with flnasteride: meta-analysis of randomised clinical trials. Urology 1996; 48: 398-405
11. Lepor H, Williford WO, Barry MJ et al. The efficacy of terazosin, tinasteride, or both in benign prostatic hyperplasia. N Engl ] Med 1996; 335; 533-9
12. Alken CE. Leitfaden der Urologie. Stuttgart: Thieme. 1973 180-2
13. Cockett ATK, Khoury S, Aso Y et a/, eds, The 2nd International Consultation on Benign Prostatic Hyperplasia. (BPH). Jersey: Scientific Communication International Ltd, 1993
14. Wasson JH. Finasteride to prevent morbidity from BPH. N Engl J Med 1998; 338: 612-3
15. Egan KJ. Krieger JN. Psychological factors in chronic prostatitis patients with pain. Clin J Pain 1994; 10: 218-26
16. Keltikangas-Järvinen L. Järvinen H, Lehtonen T. Psychic disturbances in patients with chronic prostatitis syndromes. Ann Clin Res 1981: 13: 45-9
17. Nickel JC, Sorensen R. Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized doubleblind sham-controlled study using specific assessment questionnaires. / Urol 1996: 155: 1950-5
18. Collins MM. Stafford RS, O'Leary MP, Barry MJ. How common is prostatitis? A national survey of physician visits. / Urol 1998; 159: 1224-8
19. Weidner W, Schiefer HG, Krauss H, Jantos C. Friedrich H], Altmannsberger M. Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1461 patients. Infection 1991; 19: 119-25
20. Krieger JN, Egan KJ. Comprehensive evaluation and treatment of 75 men referred to a chronic prostatitis clinic. Urology 1991: 38: 11-9
21. Krieger JN, Berger RE, Ross SO. Rothman I, Muller CH. Seminal fluid Undings in men with nonbacterial prostatitis and prostatodynia. / Androl 1996; 17: 310-88
22. Shortliffe LM, Sellers RG, Schachter J. The characterization of nonbacterial prostatitis: search for an etiology. / Urol 1992: 148: 1461-6
23. Krieger JN. Nyberg L Jr, Nickel JC. Letters to the editor: NIH Consensus Definition and Classification of Prostatitis. JAMA 1999; 282: 236-7
24. Alexander RB, Trissel D. Chronic prostatitis: results of an Internet survey. Urology 1996; 48: 568-74
25. Roberts RO, Lieber MM, Rhodes T, Girman CJ, Bostwick DG, Jacobsen SJ. Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men. Urology 1998; 51: 578-84
26. Nickel JC. Prostatitis: myth or reality? State of the art lecture. SIU congress, Montreal 1997
27. Krieger JN. Egan KJ, Ross SO, Jacobs R. Berger RE. Chronic pelvic pains represent the most prominent urogenital symptoms of 'chronic prostatitis'. Urology 1996; 48: 71522
28. Wenninger K. Heiman JR, Rothman I, Berghuis JP, Berger RE. Sickness impact of chronic nonbacterial prostatitis and its correlates. / Urol 1996; 155: 965-8
29. 5 Drabick JJ. Gambel JM, Mackey JF. Prostatodynia in United Nations peacekeeping forces in Haiti. Military Med 1997; 162: 380-16
30. Evans DTP. Treatment of chronic abacterial prostatitis: a review. M }STD AIDS 1994; 5: 157-64
31. Roberts RO, Lieber MM. Bostwick DG, Jacobsen SJ. A review of clinical and pathological prostatitis syndromes. Urology 1997:49: 809-21
32. Nickel JC, Downey ], Young I, Boag S. Asymptomatic inflammation and/or infection in benign prostatic hyperplasia. B]U hit 1999: 84: 976-81
33. Kohnen PW, Drach GW. Patterns of inflammation in prostatic hyperplasia: a histologie and bactériologie study. / Urol 1979; 121: 755-6020
34. Doble A, Thomas BJ, Walker MM et al The role of CMamydia trachomatis in chronic abacterial prostatitis: a study using ultrasound guided biopsy. / Urol 1989; 141: 332-21
35. Stamey TA. The role of introital enterobacteria in recurrent urinary infections. / Urol 1973; 109: 467-7222
36. Drach DW. Sexuality and prostatitis: a hypothesis. / Am Ven Dis Ass 1976: 3: 87-9
37. Worm AM, Petersen CS. Transmission of chlamydial infections to sexual partners. Genitourin Med 1987; 63: 19-21
38. Berger RE. Krieger JN, Kessler D et al. Case-control study of men with suspected chronic idiopathic prostatitis. / Urol 1989; 141: 328-31
39. Pavone C. Caldarera E, Liberti P et al Correlation between chronic prostatitis syndrome and pelvic venous disease. Eur Uro/2000; 37: 400-3